Spots Global Cancer Trial Database for other solid tumors harboring a ras q61x mutation
Every month we try and update this database with for other solid tumors harboring a ras q61x mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations | NCT05907304 | Advanced or Met... | Naporafenib Trametinib | 12 Years - 99 Years | Erasca, Inc. | |
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations | NCT05907304 | Advanced or Met... | Naporafenib Trametinib | 12 Years - 99 Years | Erasca, Inc. | |
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations | NCT05907304 | Advanced or Met... | Naporafenib Trametinib | 12 Years - 99 Years | Erasca, Inc. |